Skip to main content
Jianmin Pharmaceutical Group Co., Ltd. logo

Jianmin Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 600976 ISIN · CNE000001HB7 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,559 across all filing types
Latest filing 2025-04-15 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600976

About Jianmin Pharmaceutical Group Co., Ltd.

https://www.whjm.com/

Jianmin Pharmaceutical Group Co., Ltd. is a specialized pharmaceutical enterprise with a heritage dating back to 1637. The company focuses on the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern healthcare products. Its core portfolio emphasizes pediatric health, gynecological treatments, and chronic disease management. Key products include Longmu Zhuanggu Granules, recognized for supporting bone development and overall health in children. The group integrates traditional pharmacological wisdom with contemporary biotechnology and standardized production processes. Jianmin Group operates through a comprehensive value chain encompassing raw material sourcing, advanced manufacturing, and a distribution network. By leveraging its status as a time-honored brand, the company maintains a strong market position in the pediatric TCM segment while expanding its presence in general wellness and prescription drug markets.

Recent filings

Filing Released Lang Actions
健民集团2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the "2024 Annual General Meeting Resolution Announcement" of the company. It details the date and location of the AGM, attendance, voting results on various proposals including the 2024 annual report, financial budget, profit distribution, financing limits, and auditor appointment. It also includes legal opinions confirming the validity of the meeting and voting process. The content is focused on the official announcement of the AGM resolutions and voting outcomes rather than the full AGM materials or presentations. The document length is 3753 characters, which is relatively short and consistent with an announcement rather than a full report or presentation. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-04-15 Chinese
湖北得伟君尚律师事务所关于健民药业集团股份有限公司2024年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2024 Annual General Meeting (AGM) of the company. It details the convening, attendance, proposals, and voting results of the AGM. The content focuses on the legality and validity of the AGM procedures and voting outcomes rather than presenting financial data or the full annual report itself. The document length is relatively short (2584 characters) and it serves as a legal opinion on the AGM process and results, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-04-15 Chinese
健民集团2024年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as materials for the 2024 Annual General Meeting (AGM) of 健民药业集团股份有限公司, dated April 15, 2025. It includes detailed agenda items such as the 2024 Board of Directors work report, 2024 Supervisory Board work report, independent directors' reports, 2024 financial statements and budget, profit distribution plan, and the 2024 annual report. It also describes the voting procedures and meeting logistics. The content is clearly the presentation and materials shared during the AGM, not the annual report itself or voting results. The document length is substantial (15,000 characters), indicating it is the meeting materials, not a brief announcement. Therefore, the document fits the category of AGM Information (AGM-R).
2025-04-07 Chinese
健民集团监事会关于2024年年报的审核意见
Audit Report / Information Classification · 95% confidence The document is a supervisory board's audit opinion on the company's 2024 annual report. It states that the annual report complies with relevant laws and regulations and reflects the company's financial and operational status. The document is very short (331 characters) and does not contain the full annual report or detailed financial data, but rather an audit opinion or review statement. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and opinions related to annual reports, excluding the full annual report itself. FY 2024
2025-03-24 Chinese
健民集团审计委员会对中审众环2024年年度审计工作履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a detailed report from the Board Audit Committee regarding the supervision of the external auditor's work for the fiscal year 2024. It discusses the auditor's qualifications, the audit process, communication with auditors, and the evaluation of the auditor's performance. It includes references to the audit of the 2024 financial statements and internal controls, but it is not the audit report itself nor the full annual report. The document is a standalone audit-related supervisory report, consistent with the definition of an Audit Report / Information (AR). The document length is 2236 characters, which is sufficient for a substantive report rather than a brief announcement. Therefore, the appropriate classification is AR with high confidence. FY 2024
2025-03-24 Chinese
健民集团2024年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2024 年度内部控制评价报告' which translates to '2024 Annual Internal Control Evaluation Report'. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2024, including financial and non-financial internal control defects, their identification standards, and remediation status. It also references an internal control audit report issued by an accounting firm. The content is focused on internal control evaluation rather than full financial statements or annual performance. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations, distinct from a full Annual Report (10-K). The document length is 4534 characters, which is sufficient to contain substantive content rather than a brief announcement. Therefore, the classification is AR with high confidence. FY 2024
2025-03-24 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.